Diagnostic Co.'s Oversight Reforms Deal Gets Final OK
By Sydney Price · July 6, 2026, 5:24 PM EDT
A California federal judge has given final approval to a deal ending shareholder derivative claims that diagnostics company CareDx's executives and directors damaged the company by concealing its scheme to inflate...
To view the full article, register now.